Literature DB >> 15717092

Comparative clinical and ultrasound study of egg-negative and egg-positive individuals from Schistosoma mansoni low morbidity endemic areas, and hospitalized patients with hepatosplenic disease.

Telcia V B Magalhães1, Giovanni Gazzinelli, Maria Carolina B Alvarez, F C Lima e Silva, Lucia Alves Oliveira Fraga, Alda Maria S Silveira, Andrea Gazzinelli, Jeffrey Bethony, Philip LoVerde, Iramaya R Caldas, Rodrigo Correa-Oliveira, Aluízio Prata.   

Abstract

Two hundred and twenty three subjects from a Schistosoma mansoni low morbidity endemic area and nine hospitalized hepatosplenic patients were submitted to stool test and clinical examination and abdomen ultrasound assessments. According to stool examination and ultrasound results, they were grouped as follows: G1 -- 63 Schistosoma mansoni egg-negative individuals; G2 -- 141 egg-positive patients and without evidence of periportal fibrosis; G3 -- 19 egg-positive patients with periportal echogenicity (3-6 mm); and G4 -- 9 hepatosplenic patients with periportal echogenicity (> 6 mm). Hepatomegaly detected by physical examination of the abdomen evaluated in the midclavicular line was verified in G1, G2 and G3, respectively, in 11.1, 12.1 and 26.3%. In G1, G2 and G3, periportal thickening occurred only in schistosomal patients (8.5%). Mild pathological alterations in patients that cannot yet be detected by clinical examination were detectable in the liver by ultrasound and can be due to fibrosis. The degree of mild periportal fibrosis was diminished in 57.9% of patients 12 months after treatment of schistosomiasis with oxamniquine. At ultrasonography, the mean liver left lobe measurement of G3 was larger than that of G1, and that of G4 larger than that of G1 and G2. The mean size of the spleen of G4 was significantly larger than that of the other three groups, and that of G3 larger than that of G1 and G2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15717092     DOI: 10.1590/s0037-86822005000100007

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

Review 1.  Ultrasonography of gallbladder abnormalities due to schistosomiasis.

Authors:  Joachim Richter; Daniel Azoulay; Yi Dong; Martha C Holtfreter; Robert Akpata; Julien Calderaro; Tarik El-Scheich; Matthias Breuer; Andreas Neumayr; Christoph Hatz; Gerald Kircheis; Monica C Botelho; Christoph F Dietrich
Journal:  Parasitol Res       Date:  2016-05-12       Impact factor: 2.289

Review 2.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

3.  Immunomodulatory effect of R848 on cytokine production associated with Schistosoma mansoni infection.

Authors:  Ghada Boghdadi; Dalia Abdel Khalik; Sami Abdel Wahab; Adel Farghaly
Journal:  Parasitol Res       Date:  2012-09-20       Impact factor: 2.289

4.  Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans.

Authors:  L F Alves Oliveira; E C Moreno; G Gazzinelli; O A Martins-Filho; A M S Silveira; A Gazzinelli; L C C Malaquias; P LoVerde; P Martins Leite; R Correa-Oliveira
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Effect of chemotherapy with praziquantel on the production of cytokines and morbidity associated with schistosomiasis mansoni.

Authors:  P Martins-Leite; G Gazzinelli; L F Alves-Oliveira; A Gazzinelli; L C C Malaquias; R Correa-Oliveira; A Teixeira-Carvalho; A M S Silveira
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.